Procedure Guide


IVC Filter Placement

  • Absolute indications

    • Acute proximal (at least popliteal) DVT or PE with inability to achieve therapeutic anticoagulation or contraindication such as recent surgery, intracranial hemorrhage, active bleeding, vascular brain tumor

    • CTEPH prior to pulmonary thromboendarterectomy

    • Recurrent embolization despite anticoagulation

  • Relative indications

    • Iliocaval DVT or large residual “widow-maker” thrombus in IVC/iliacs

    • Massive PE treated with catheter directed therapy

    • VTE with limited cardiopulmonary reserve

    • High risk of bleeding from anticoagulation, e.g., recurrent falls

    • Trauma with high VTE risk

    • Surgical patient with high risk for VTE

IVC Filter Removal

  • Indwelling filters should be removed as soon as it is safe to do so, i.e., once tolerating anticoagulation or recovered from trauma or surgery.

  • For insurance coverage for advanced removal techniques, it is important to assess for and document filter-related anxiety and/or symptoms (e.g. back/abdominal pain)


  • Device allergy

  • Total IVC occlusion

  • INR > 3.0, Plts < 25K

  • Bacteremia, *NOT sepsis*

  • HIT per Hematology 2018 guidelines but studies suggest this may be over blown

  • Pregnancy is debated. The mass effect from the uterus can theoretically serve as a physiologic IVC filter and is higher risk requiring suprarenal placement.


  • Successful deployment >99%. Retrieval rates very high if removed within 3 months and nearly 100% with ancillary techniques even for prolonged dwell times.

  • PREPIC1: RCT of 400 pts with proximal DVT assigned to anticoagulation alone or with IVC filter. During first 12d, PE lower with filter (1 v. 5%). At 8 yrs, no difference in survival, PE less with filter (6 v. 15%) but DVT higher (21 v. 12%).

  • PREPIC2: RCT of 399 pts with severe PE assigned to anticoagulation alone or with IVC filter. No difference in PE, mortality, or DVT at 3mo.

  • PRESERVE: multicenter, prospective, non-randomized, followed 1429 pts. Filter removed in 44%, post-filter VTE occurred in 6.5% (1.6% PE, 5.2% DVT, 1.1% cava thrombosis/obstruction), no PE in pts who received the filter for prophylaxis. Successful filter removal in 99% of those attempted, 97% at first attempt.


  • Review imaging and VTE/filter history as applicable

    • Aberrant IVC anatomy: circumferential left renal (7%), duplicated IVC (1%), megacava (1%), left IVC (<1%)

  • Labs: coags, CBC, BMP for INR <3, Plt >25K, Cr <1.5 (debatable)

  • Meds: No need to hold anticoagulation

  • Some give prophylactic antibiotics for retrieval if filter leg penetration of adjacent bowel.


Filter Placement

  • Obtain access: Internal jugular > external jugular, femoral > subclavian, translumbar.

    • NOTE: Need to select appropriate filter designed for approach, e.g., IJ vs femoral. Some allow either with same device set, e.g., Option Elite (Argon).

  • Advance working wire (e.g. Amplatz) into IVC.

  • Advance sheath - often the filter comes with a delivery sheath, which can be used for venography.

  • IVC venogram to identify caval anomalies and level of renal venous inflow to plan placement. Helpful to “prime” sheath by filling with contrast and then inject for the venogram with a second syringe, particularly for larger sheaths. This can be done with a 3-way with both syringes attached.

    • Classic teaching is to place below the level of the renal veins (infrarenal) with filter apex near the level of the renal veins.

    • Suprarenal placement can be done in the setting of renal venous thrombus, duplicated IVC, or pregnancy. This comes with increased risks.

    • Some will use a retrievable filter for all [e.g. Gunther-Tulip (Cook), Option Elite (Argon)]. Others will use permanent filters (e.g. Vena Tech) if highly unlikely to be removed such as a patient with end-stage malignancy due to some evidence that permanent filters have less long-term complications.

    • If megacava (>28 mm), most filters are too small and may require placing bilateral common iliac vein fitlers.

  • Exchange for deployment system and deploy

  • (Optional) Repeat venogram.

  • Spot image of the filter to document positioning and appearance at the end of the case.

  • Achieve hemostasis

Filter Retrieval

  • Magnified spot image of the filter to assess for and document fracture or missing struts prior to manipulation.

  • Obtain access - often just right internal jugular but concurrent femoral access can be helpful for advanced, challenging retrievals.

  • Advance working wire passed the filter in the IVC.

  • Advance a long sheath large enough to accommodate the filter as well as any devices to be used, often 9-16 Fr. Leave sheath tip near filter apex.

  • IVC venogram to assess for filling defects in the filter, fibrin cap, and filter positioning relative to the cava.

    • Helpful to “prime” sheath by filling with contrast and then inject for the venogram with a second syringe, particularly for larger sheaths. This can be done with a 3-way with both syringes attached.

    • If large amount of intrafilter thrombus, many will terminate the procedure and bring the patient back after further anticoagulation. Some have described attempting aspiration thrombectomy and proceeding.

  • (Optional) Some use IVUS for further assessment, e.g., relationship between an embedding apex and the right renal artery.

  • Basic retrieval

    • Advance EnSnare or device-specific retrieval device. Often engaging a small hook at the apex allowing the sheath to be advanced over the filter and freeing it from the caval wall.

  • Advanced retrieval

    • Loop-snare technique - use a curved catheter through the sheath (e.g. C2, RIM, Kumpe) to advance a glidewire through the filter interstices near the apex. Advance a snare to snare the end of the glidewire and pull through the sheath so both ends of the wire are out of the patient. Pull wire to help straighten a tilted filter and engage the apex with the sheath. Also good for filters with no hook.

    • Forceps - good for microdissection of a fibrin cap and to engage the apex. Can then pull to straighten the filter and engage it with the sheath.

    • Excimer laser - good for scarring and penetration of filter legs with the caval wall to carefully strip the filter legs off the wall.

  • Unsuccessful retrieval

    • Many will abort the procedure and consider referral to high volume center or attempting again on a different day.

    • Otherwise, a stent can be placed to crush the filter against the caval wall and exclude it. Should be done cautiously as these prohibits further retrieval attempts.

  • Post-removal venogram to assess the caval injury.

  • Venoplasty/stenting if significant caval injury.

    • Small irregularities and pseudoaneurysms often resolve without intervention.

    • A soft sizing balloon can be used to assess for significant narrowing by inflating it caudal to the prior filter site and pulling it across the prior filter site.

    • Larger pseudoaneurysms and stenoses often respond to venoplasty alone. Large volume extravation may require stent placement.

  • Achieve hemostasis


  • Overall, highly safe and effective in the PRESERVE study

  • Adverse events in ~2% during implantation, e.g., tilted filter, migration, fracture, hematoma, tachycardia, groin pain

  • IVC perforation (>5 mm, 15%)

  • Post-filter VTE 6.5% (1.6% PE, 5.2% DVT, 1.1% cava thrombosis/obstruction)

    • Other studies report rate of caval thrombus of 2% (risk factors: male gender, neurologic dx, implantation >6mo)

  • Pericardial tamponade (2%, SVC placement) - not recommended any more

  • One patient died during attempted removal in PRESERVE study


  • Start anticoagulation as soon as not contraindicated

  • Some suggest abdominal XR every 3-5 yrs to monitor position for permanent filters. This is probably unnecessary


Decision Aids for Patients and Consent

Backtable Articles and Podcasts on IVC Filters

SIR Practice Guideline on IVC Filters